"Cholecystokinin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.
| Descriptor ID |
D002766
|
| MeSH Number(s) |
D06.472.317.152 D12.644.120
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cholecystokinin".
Below are MeSH descriptors whose meaning is more specific than "Cholecystokinin".
This graph shows the total number of publications written about "Cholecystokinin" by people in this website by year, and whether "Cholecystokinin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholecystokinin" by people in Profiles.
-
Mottalib A, Abrahamson MJ, Pober DM, Polak R, Eldib AH, Tomah S, Ashrafzadeh S, Hamdy O. Effect of diabetes-specific nutrition formulas on satiety and hunger hormones in patients with type 2 diabetes. Nutr Diabetes. 2019 09 24; 9(1):26.
-
Kierson JA, Dimatteo DM, Locke RG, Mackley AB, Spear ML. Ghrelin and cholecystokinin in term and preterm human breast milk. Acta Paediatr. 2006 Aug; 95(8):991-5.
-
Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S, Waldman SA. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest. 1997 Aug 01; 100(3):597-603.
-
Obourn JD, Frame SR, Bell RH, Longnecker DS, Elliott GS, Cook JC. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643. Toxicol Appl Pharmacol. 1997 Aug; 145(2):425-36.
-
Lu LJ, Anderson KE, Gomez G, Nealon WH. Decreased plasma levels of cholecystokinin in healthy males after chronic ingestion of a heat-treated soya product. Cancer Lett. 1995 Apr 14; 90(2):149-55.
-
Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors. Gastroenterology. 1994 Oct; 107(4):1135-46.
-
Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Ann N Y Acad Sci. 1994 Mar 23; 713:439-41.
-
Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 1993 Sep 01; 53(17):3925-9.
-
Beauchamp RD, MacLellan DG, Upp JR, Nealon WH, Townsend CM, Thompson JC. The role of endogenous prostaglandins in hormone-stimulated pancreatic exocrine secretion. Gastroenterology. 1992 Jan; 102(1):272-9.
-
Beauchamp RD, Gomez G, Nealon WH, Townsend CM, Greeley GH, Thompson JC. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide. Surgery. 1990 Sep; 108(3):553-8.